Mitogen-activated protein kinase-activated protein kinase 2 (MK2) in skeletal muscle atrophy and hypertrophy

Journal of Cellular Physiology

Volumn 223, Issue 1, 2010, Pages 194-201

  Norrby, Marlene ^a   Tågerud, Sven ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEMIDIAPHRAGM; HINDLIMB; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; DENERVATION; DIAPHRAGM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HINDLIMB; HYPERTROPHY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; TIME FACTORS;

EID: 75749128621     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22023     Document Type: Article

References (63)

1. Adams V, Mangner N, Gasch A, Krohne C, Gielen S, Hirner S, Thierse HJ,Witt CC, Linke A, Schuler G, Labeit S. 2008. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. J Mol Biol 384:48-59.
2. Asada S,Daitoku H, MatsuzakiH, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, KishiT,Kasuya Y, Fukamizu A. 2007. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19:519-527.
3. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ, Cohen P. 1995. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J 14:5920-5930.
4. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. 1998. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8:1049-1057.
5. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, Lutsch G. 1994. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 269:20780-20784.
6. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001a. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708.
7. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. 2001b. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019.
8. Boppart MD, Hirshman MF, Sakamoto K, Fielding RA, Goodyear LJ. 2001. Static stretch increases c-Jun NH2-terminal kinase activity and p38 phosphorylation in rat skeletal muscle. Am J Physiol Cell Physiol 280:C352-358.
9. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
10. Cano E, Doza YN, Ben-Levy R, Cohen P, Mahadevan LC. 1996. Identification of anisomycinactivated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene 12:805-812.
11. Dodd SL, Hain B, Senf SM, Judge AR. 2009. Hsp27 inhibits IKK{beta}-induced NF-{kappa}B activity and skeletal muscle atrophy. FASEB J 23:3415-3423.
12. Eddy SF, Storey KB. 2007. p38 MAPK regulation of transcription factor targets in muscle and heart of the hibernating bat, Myotis lucifugus. Cell Biochem Funct 25:759-765.
13. Eddy SF, McNally JD, Storey KB. 2005. Up-regulation of a thioredoxin peroxidase-like protein, proliferation-associated gene, in hibernating bats. Arch Biochem Biophys 435:103-111.
14. Engel K, Schultz H, Martin F, Kotlyarov A, Plath K, Hahn M, Heinemann U, Gaestel M. 1995. Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem 270:27213-27221.
15. Engel K, Kotlyarov A, Gaestel M. 1998. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17:3363-3371.
16. Favier FB, Benoit H, Freyssenet D. 2008. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch 456:587-600.
17. Feng TP, Lu DX. 1965. New lights on the phenomenon of transient hypertrophy in the denervated hemidiaphragm of the rat. Sci Sin 14:1772-1784.
18. Frost RA, Lang CH. 2007. Protein kinase B/Akt: A nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 103:378-387.
19. Gaestel M. 2006. MAPKAP kinases - MKs - two's company, three's a crowd. Nat Rev Mol Cell Biol 7:120-130.
20. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98:14440-14445.
21. Gorog DA, Jabr RI, Tanno M, Sarafraz N, Clark JE, Fisher SG, Cao XB, Bellahcene M, Dighe K, Kabir AM, Quinlan RA, Kato K, Gaestel M, Marber MS, Heads RJ. 2009. MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia. Cell Stress Chaperones 14:477-489.
22. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J. 1997. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110:357-368.
23. Gutmann E, Hanikova M, Hajek I, Klicpera M, Syrovy I. 1966. The postdenervation hypertrophy of the diaphragm. Physiol Bohemoslov 15:508-524.
24. Hornberger TA, Chien S. 2006. Mechanical stimuli and nutrients regulate rapamycin-sensitive signaling through distinct mechanisms in skeletal muscle. J Cell Biochem 97:1207-1216. Hresko RC, MuecklerM. 2005. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280:40406-40416.
25. Huang J, Manning BD. 2008. The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem J 412:179-190.
26. Huang H, Tindall DJ. 2007. Dynamic FoxO transcription factors. J Cell Sci 120:2479-2487.
27. Huey KA. 2006. Regulation of HSP25 expression and phosphorylation in functionally overloaded rat plantaris and soleus muscles. J Appl Physiol 100:451-456.
28. Huey KA, McCall GE, Zhong H, Roy RR. 2007. Modulation of HSP25 and TNF-alpha during the early stages of functional overload of a rat slow and fast muscle. J Appl Physiol 102:2307-2314.
29. Ito Y, Obara K, Ikeda R, Ishii M, Tanabe Y, Ishikawa T, Nakayama K. 2006. Passive stretching produces Akt- and MAPK-dependent augmentations of GLUT4 translocation and glucose uptake in skeletal muscles of mice. Pflugers Arch 451:803-813.
30. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125-137.
31. Jin B, Li YP. 2007. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J Cell Biochem 100:960-969.
32. Kawano F, Matsuoka Y, Oke Y, Higo Y, Terada M, Wang XD, Nakai N, Fukuda H, Imajoh-Ohmi S, Ohira Y. 2007. Role(s) of nucleoli and phosphorylation of ribosomal protein S6 and/or HSP27 in the regulation of muscle mass. Am J Physiol Cell Physiol 293:C35-44.
33. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1:94-97.
34. KotlyarovA, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D, Lin LL, Gaestel M. 2002. Distinct cellular functions of MK2. Mol Cell Biol 22:4827-4835.
35. Lee CH, Inoki K, Guan KL. 2007. mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 47:443-467.
36. Li Y, Inoki K, Vacratsis P, Guan KL. 2003. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J Biol Chem 278:13663-13671.
37. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. 2005. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19:362-370.
38. MacDonald JA, Storey KB. 2005. Mitogen-activated protein kinases and selected downstream targets display organ-specific responses in the hibernating ground squirrel. Int J Biochem Cell Biol 37:679-691.
39. Magnusson C, Hogklint L, Libelius R, Tagerud S. 2001. Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle. J Neurosci Res 66:457-463.
40. Magnusson C, Libelius R, Tagerud S. 2003. Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle. Mol Cell Neurosci 22:298-307.
41. Meng W, Swenson LL, Fitzgibbon MJ, Hayakawa K, Ter Haar E, Behrens AE, Fulghum JR, Lippke JA. 2002. Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J Biol Chem 277:37401-37405.
42. Neininger A, Thielemann H, Gaestel M. 2001. FRET-based detection of different conformations of MK2. EMBO Rep 2:703-708.
43. Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, PierceW, Ping P, McLeish KR. 2001. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositidedependent kinase-2 for Akt in human neutrophils. J Biol Chem 276:3517-3523.
44. Rommel C, Bodine SC,Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013.
45. Rosner M, Hanneder M, Siegel N, Valli A, Hengstschlager M. 2008. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res 658:234-246.
46. Sakamoto K, Aschenbach WG, Hirshman MF, Goodyear LJ. 2003. Akt signaling in skeletal muscle: Regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285:E1081-1088.
47. Sandri M. 2008. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160-170.
48. SandriM, SandriC,Gilbert A, SkurkC, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412.
49. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
50. Shavlakadze T, Grounds M. 2006. Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. Bioessays 28:994-1009.
51. Sola OM, Martin AW. 1953. Denervation hypertrophy and atrophy of the hemidiaphragm of the rat. Am J Physiol 172:324-332.
52. Stewart CE, Rittweger J. 2006. Adaptive processes in skeletal muscle: Molecular regulators and genetic influences. J Musculoskelet Neuronal Interact 6:73-86.
53. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, GonzalezM, Yancopoulos GD, Glass DJ. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophyinduced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403.
54. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall C, Cohen P. 1992a. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J 11:3985-3994.
55. Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M. 1992b. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313:307-313.
56. Stokoe D, Caudwell B, Cohen PT, Cohen P. 1993. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem J 296:843-849.
57. Sudo T, Kawai K, Matsuzaki H, Osada H. 2005. p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem Biophys Res Commun 337:415-421.
58. ter Haar E, Prabhakar P, Liu X, Lepre C. 2007. Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer. J Biol Chem 282:9733-9739.
59. Thomas T, Timmer M, Cesnulevicius K, Hitti E, Kotlyarov A, Gaestel M. 2008. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation-relevance in a mouse model of Parkinson's disease. J Neurochem 105:2039-2052.
60. White A, Pargellis CA, Studts JM, Werneburg BG, Farmer BT II. 2007. Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci USA 104:6353-6358.
61. Wu R, Kausar H, Johnson P, Montoya-Durango DE, Merchant M, Rane MJ. 2007. Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J Biol Chem 282:21598-21608.
62. Zhang P, Chen X, Fan M. 2007. Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses 69:310-321.
63. Zheng C, Lin Z, Zhao ZJ, Yang Y, Niu H, Shen X. 2006. MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J Biol Chem 281:37215-37226.